Article Dans Une Revue Clinical Gastroenterology and Hepatology Année : 2024
Fichier non déposé

Dates et versions

hal-04872903 , version 1 (08-01-2025)

Identifiants

Citer

Xavier Roblin, Estelle Moschetti, Mathilde Barrau, Adam Cheifetz, Konstantinos Papamichael, et al.. Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology, 2024, 22 (11), pp.2340-2343.e2. ⟨10.1016/j.cgh.2024.03.039⟩. ⟨hal-04872903⟩
32 Consultations
0 Téléchargements

Altmetric

Partager

  • More